These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4959828)

  • 1. Antinuclear antibodies following hydralazine toxicity.
    Condemi JJ; Moore-Jones D; Vaughan JH; Perry HM
    N Engl J Med; 1967 Mar; 276(9):486-91. PubMed ID: 4959828
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of hypertension and systemic lupus erythematosus.
    Vogl A
    Proc Rudolf Virchow Med Soc City N Y; 1970-1971; 28():157-8. PubMed ID: 5293512
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus.
    Hahn BH; Sharp GC; Irvin WS; Kantor OS; Gardner CA; Bagby MK; Perry HM; Osterland CK
    Ann Intern Med; 1972 Mar; 76(3):365-74. PubMed ID: 4536922
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype.
    Russell GI; Bing RF; Jones JA; Thurston H; Swales JD
    Q J Med; 1987 Oct; 65(246):845-52. PubMed ID: 3329739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute immunologic hydralazine reaction. Clinical and serological changes after hydralazine administration to a patient with circulating antinuclear antibodies.
    Alarcón-Segovia D
    Rev Invest Clin; 1972; 24(2):167-74. PubMed ID: 4538312
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced lupus: clinical and serological studies.
    Harmon CE; Portanova JP
    Clin Rheum Dis; 1982 Apr; 8(1):121-35. PubMed ID: 6811188
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug-induced lupus erythematosus-like syndromes].
    Cohmen G
    Med Klin; 1976 May; 71(19):789-98. PubMed ID: 1083935
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic lupus erythematosus following prolonged treatment with hydralazine.
    Alkalay I; Bullard JC
    Ann Allergy; 1971 Jan; 29(1):35-6. PubMed ID: 4118529
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocytotoxic antibodies in hydralazine-induced lupus erythematosus.
    Ryan PF; Hughes GR; Bernstein R; Mansilla R; Dollery CT
    Lancet; 1979 Dec; 2(8154):1248-9. PubMed ID: 92663
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
    Ullman S; Wiik A; Kobayasi T; Halberg P
    Acta Derm Venereol; 1974; 54(5):387-90. PubMed ID: 4138086
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydralazine, antinuclear antibodies, and the lupus syndrome.
    Mansilla-Tinoco R; Harland SJ; Ryan PJ; Bernstein RM; Dollery CT; Hughes GR; Bulpitt CJ; Morgan A; Jones JM
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):936-9. PubMed ID: 6802356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sweet syndrome associated with hydralazine-induced lupus erythematosus.
    Cartee TV; Chen SC
    Cutis; 2012 Mar; 89(3):121-4. PubMed ID: 22530328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydralazine-induced lupus syndrome.
    French WJ
    Ala J Med Sci; 1984 Oct; 21(4):427-30. PubMed ID: 6507805
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced autoimmune disease.
    Tan EM
    Fed Proc; 1974 Aug; 33(8):1894-7. PubMed ID: 4135739
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective study of immunologic effects of hydralazine in hypertensive patients.
    Litwin A; Adams LE; Zimmer H; Foad B; Loggie JH; Hess EV
    Clin Pharmacol Ther; 1981 Apr; 29(4):447-56. PubMed ID: 6970646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constrictive pericarditis due to hydralazine-induced lupus erythematosus.
    Richards FM; Fulkerson WJ
    Am J Med; 1990 Jan; 88(1N):56N-59N. PubMed ID: 2368766
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydrallazine in hypertension: is there a safe dose?
    Bing RF; Russell GI; Thurston H; Swales JD
    Br Med J; 1980 Aug; 281(6236):353-4. PubMed ID: 6968614
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical grand rounds--from the Medical College of Virginia. Drug-induced lupus erythematosus.
    Va Med Mon (1918); 1974 Apr; 101(4):299-301 passim. PubMed ID: 4545011
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydralazine-induced Lupoid syndrome. Biochemical and immunological studies.
    Blumenkrantz N; Christiansen AH; Ullman S; Asboe-Hansen G
    Acta Med Scand; 1974 Jun; 195(6):443-9. PubMed ID: 4134858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.